Trial of Buprenorphine/Naloxone for Opiate Dependence - 2

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Treatments

Drug: Buprenorphine/naloxone

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000353
Y01-3-0012-2
NIDA-3-0012-2

Details and patient eligibility

About

The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.

Sex

All

Ages

19 to 57 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems